Insider Trading & Ownership - Lutz Robert Matthew

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Lutz Robert Matthew
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-03-10
Sale
2022-03-14
4:12 pm
iBio Inc.IBIOLutz Robert Matthew
See Remarks
24,625$0.3456$8,510207,375
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-12-14
Option Award
2023-12-15
5:51 pm
N/A
2033-12-14
Savara IncSVRALutz Robert Matthew
Chief Operating Officer
200,000$0340,000
(Direct)
View
2023-02-24
Option Award
2023-02-28
4:31 pm
N/A
2033-02-24
Savara IncSVRALutz Robert Matthew
Chief Operating Officer
490,000$0490,000
(Direct)
View
2022-11-11
Option Award
2022-11-15
08:33 am
N/A
N/A
iBio Inc.IBIOLutz Robert Matthew
See Remarks
100,057$0102,165
(Direct)
View
2022-08-29
Option Award
2022-08-31
4:01 pm
N/A
2032-08-28
iBio Inc.IBIOLutz Robert Matthew
See Remark
400,000$0400,000
(Direct)
View
2021-08-23
Option Award
2021-08-25
8:32 pm
N/A
2031-08-22
iBio Inc.IBIOLutz Robert Matthew
See Remarks
500,000$0500,000
(Direct)
View
2021-03-04
Option Award
2021-03-04
9:30 pm
2022-03-04
2031-03-04
iBio Inc.IBIOLutz Robert Matthew
See Remarks
582,000$0582,000
(Direct)
View
2021-02-22
Tax Withholding
2021-02-23
5:16 pm
N/A
N/A
Strongbridge Biopharma plcSBBPLutz Robert Matthew
Chief Financial Officer
6,978$3.62181,333
(Direct)
View
2021-01-07
Option Award
2021-01-08
08:35 am
N/A
N/A
Strongbridge Biopharma plcSBBPLutz Robert Matthew
Chief Financial Officer
147,500$0188,311
(Direct)
View
2020-01-27
Option Award
2020-01-29
6:25 pm
N/A
2030-01-27
Strongbridge Biopharma plcSBBPLutz Robert Matthew
Chief Financial Officer
275,000$0275,000
(Direct)
View